A phase 1 study of combination chemotherapy for hepatocellular carcinoma using Miripla (SM11355) and IA-call (DDP-H)

Trial Profile

A phase 1 study of combination chemotherapy for hepatocellular carcinoma using Miripla (SM11355) and IA-call (DDP-H)

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2016

At a glance

  • Drugs Cisplatin (Primary) ; Miriplatin (Primary)
  • Indications Liver cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top